California Public Employees Retirement System’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-23,900
Closed -$1.64M 1880
2021
Q1
$1.64M Sell
23,900
-2,181
-8% -$164K ﹤0.01% 2155
2020
Q4
$1.75M Sell
26,081
-1,070
-4% -$58K ﹤0.01% 2080
2020
Q3
$1.4M Buy
27,151
+4,513
+20% +$201K ﹤0.01% 2045
2020
Q2
$853K Buy
+22,638
New +$773K ﹤0.01% 2341

Other funds holding CSTL

California Public Employees Retirement System's CSTL Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Castle Biosciences (CSTL) in Q2 2021, closing a stake of 23,900 shares — an estimated $1.64M sold.

California Public Employees Retirement System first reported a position in CSTL in Q2 2020 and held it in 4 quarters. The position peaked at $1.75M in Q4 2020. 181 funds tracked by Wall St. Rank hold CSTL as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Castle Biosciences position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 23,900 Castle Biosciences shares in Q2 2021, an estimated $1.64M.
  • California Public Employees Retirement System first reported a position in Castle Biosciences in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Castle Biosciences position peaked at $1.75M in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.